On November 24, Shenzhen Cell Valley was invited to participate in the 2023IVB Shenzhen - Focus on Gene Cell Therapy & Nucleic Acid Drug Summit, which was sponsored by Shanghai Bomass Medical Service Co., LTD., Cell Medicine Branch of China Food and Drug Promotion Association, and Professional Committee of Quality uation and Standard of Vaccines and biological products with the theme of "Biotechnology to give new life". The summit focused on revolutionary breakthroughs in innovative medicines such as gene cell therapy, and together with industry leaders, experts and innovators, explored the potential of genetic medicine to empower patients with new opportunities.

Dr. Zhao Lijun, Director of Research and Development Department of our company, attended the conference and delivered a keynote speech entitled "Current Situation and Prospect of Cell therapy", in-depth introduction of the development background, current development status and future development trend of cell therapy, and focused on the advantages of industrial retrovirus carrier technology (PackRV-SS), the core technology of Shenzhen Cell Valley. As an enterprise in the field of cutting-edge innovative biotechnology - cell and gene therapy, Shenzhen Cell Valley focuses on solving the bottleneck of large-scale industrial production in the field of cell and gene therapy. Through active participation in exchanges and cooperation at home and abroad, Shenzhen Cell Valley has established strategic cooperative relations with domestic leading enterprises, medical institutions, scientific research institutions and universities. Jointly promote the research and development, clinical practice and application of cell therapy drugs, help transform scientific research results, and benefit more patients.